Hepatology

NEW research has uncovered a molecular pathway that may drive the progression of liver fibrosis

The MVX score may help identify patients with MASLD who are at greatest risk of death and liver-related complications.

Steatotic liver disease is placing a growing strain on health systems across Latin America, driven by metabolic risk factors, alcohol use and genetic susceptibility.

Study links AKAP1-driven glycogen reprogramming to liver cancer growth and highlights a potential new targeted therapy for HCC.

Frailty may help identify people with MASLD at increased risk of cardiovascular events and death, according to findings from a large UK Biobank study.

Acute hepatitis C cases in Madrid MSM cohort show high chemsex and slamsex rates, with low spontaneous clearance and gaps in follow-up care.

A multicentre study suggests selected Child-Pugh B liver cancer patients may benefit from first-line atezolizumab/bevacizumab despite poorer survival outcomes.

In 252 adults with autoimmune liver disease, health related quality of life remained stable over 35 months, with modest psychological improvement and poorer outcomes in women and those with MASLD or ascites.